Citations (15)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Debra E. Irwin, Kathleen Wilson, Gerard Hoehn, Stella Min & Erika Szabo. (2020) Real-world healthcare resource utilization in patients with indolent non-Hodgkin lymphoma: differences between patients treated with first-line ibrutinib or bendamustine + rituximab. Current Medical Research and Opinion 36:3, pages 439-444.
Read now
Read now
Husam Albarmawi, Madhuram Nagarajan, Kai Sun, Aakash Bipin Gandhi, Jean Yared, Karen N. Keating, Sreevalsa Appukkuttan, Avin Yaldo, Mecide Gharibo & Eberechukwu Onukwugha. (2020) Costs associated with follicular lymphoma among individuals diagnosed with non-Hodgkin lymphoma: a longitudinal analysis using SEER-Medicare data. Leukemia & Lymphoma 61:1, pages 75-83.
Read now
Read now
Articles from other publishers (13)
Marjan ZakeriJieni LiSujit S SansgiryRajender R Aparasu. (2023) Incremental health care expenditures for non-Hodgkin lymphoma in comparison with other cancers: Analysis of national survey data. Journal of Managed Care & Specialty Pharmacy 29:5, pages 480-489.
Crossref
Crossref
John Kuruvilla, Emmanuel M. Ewara, Julia Elia-Pacitti, Ryan Ng, Maria Eberg, Atif Kukaswadia & Arushi Sharma. (2023) Estimating the Burden of Illness of Relapsed Follicular Lymphoma and Marginal Zone Lymphoma in Ontario, Canada. Current Oncology 30:5, pages 4663-4676.
Crossref
Crossref
Virginie Nerich, Christophe Guyeux, Michel Henry‐Amar, Raphaël Couturier, Catherine Thieblemont, Vincent Ribrag, Hervé Tilly, Corinne Haioun, René‐Olivier Casasnovas, Franck Morschhauser, Pierre Feugier, David Sibon, Loic Ysebaert, Emmanuelle Nicolas‐Virelizier, Florence Broussais‐Guillaumot, Gandhi L. Damaj, Jean‐Philippe Jais, Gilles Salles, Macha Woronoff‐Lemsi & Nicolas Mounier. (2021) Economic burden in non‐Hodgkin lymphoma survivors: The French Lymphoma Study Association SIMONAL cross‐sectional study. Cancer 128:3, pages 519-528.
Crossref
Crossref
Saaya Tsutsué, Kensei Tobinai, Jingbo Yi & Bruce Crawford. (2021) Comparative effectiveness study of chemotherapy in follicular lymphoma patients in the rituximab era: a Japanese claims database study. Future Oncology 17:4, pages 455-469.
Crossref
Crossref
Cromwell Prince Dawson, Genevieve Cecilia Aryeetey, Samuel Agyei Agyemang, Kofi Mensah, Rebecca Addo & Justice Nonvignon. (2021) Costs, burden and quality of life associated with informal caregiving for children with Lymphoma attending a tertiary hospital in Ghana. International Journal of Care Coordination 23:4, pages 165-172.
Crossref
Crossref
Neerav Monga, Jamie Garside, Binu Gurung, Joan Quigley, Peter O’Donovan, Christoph Tapprich, Loretta Nastoupil, Catherine Thieblemont & Christina Loefgren. (2020) Cost-Effectiveness Analyses, Costs and Resource Use, and Health-Related Quality of Life in Patients with Follicular or Marginal Zone Lymphoma: Systematic Reviews. PharmacoEconomics - Open 4:4, pages 575-591.
Crossref
Crossref
Erwan Beauchamp, Megan C. Yap, Aishwarya Iyer, Maneka A. Perinpanayagam, Jay M. Gamma, Krista M. Vincent, Manikandan Lakshmanan, Anandhkumar Raju, Vinay Tergaonkar, Soo Yong Tan, Soon Thye Lim, Wei-Feng Dong, Lynne M. Postovit, Kevin D. Read, David W. Gray, Paul G. Wyatt, John R. Mackey & Luc G. Berthiaume. (2020) Targeting N-myristoylation for therapy of B-cell lymphomas. Nature Communications 11:1.
Crossref
Crossref
Carolina Reyes, Nicole M. Engel-Nitz, Stacey DaCosta Byfield, Arliene Ravelo, Sarika Ogale, Tim Bancroft, Amy Anderson, May Chen & Matthew Matasar. (2019) Cost of Disease Progression in Patients with Chronic Lymphocytic Leukemia, Acute Myeloid Leukemia, and Non-Hodgkin's Lymphoma. The Oncologist 24:9, pages 1219-1228.
Crossref
Crossref
Neerav Monga, Loretta Nastoupil, Jamie Garside, Joan Quigley, Moira Hudson, Peter O’Donovan, Lori Parisi, Christoph Tapprich & Catherine Thieblemont. (2018) Burden of illness of follicular lymphoma and marginal zone lymphoma. Annals of Hematology 98:1, pages 175-183.
Crossref
Crossref
Vicki A Morrison, Jill A Bell, Laurie Hamilton, Augustina Ogbonnaya, Huai-Che Shih, Kristin Hennenfent, Michael Eaddy, Yaping Shou & Aaron Galaznik. (2018) Economic burden of patients with diffuse large B-cell and follicular lymphoma treated in the USA. Future Oncology 14:25, pages 2627-2642.
Crossref
Crossref
Han-I Wang, Eve Roman, Simon Crouch, Eline Aas, Cathy Burton, Russell Patmore & Alexandra Smith. (2018) A Generic Model for Follicular Lymphoma: Predicting Cost, Life Expectancy, and Quality-Adjusted-Life-Year Using UK Population–Based Observational Data. Value in Health 21:10, pages 1176-1185.
Crossref
Crossref
Clara Chen, Rahul Dhanda, Wan-Yu Tseng, Michael Forsyth & Debra A. Patt. (2013)
Evaluating Use Characteristics for the Onco
type
Dx 21-Gene Recurrence Score and Concordance With Chemotherapy Use in Early-Stage Breast Cancer
. Journal of Oncology Practice 9:4, pages 182-187.
Crossref
Crossref
Erkki J. Soini, Janne A. Martikainen, Ville Vihervaara, Kim Mustonen & Tapio Nousiainen. (2012) Economic Evaluation of Sequential Treatments for Follicular Non-Hodgkin Lymphoma. Clinical Therapeutics 34:4, pages 915-925.e2.
Crossref
Crossref